Androgen Deprivation Therapy for Prostate Cancer — An Interview with Dr Rana R McKay
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
Androgen Deprivation Therapy for Prostate Cancer — An Interview with Dr Rana R McKay
-
Narrated by:
-
By:
Featuring an interview with Dr Rana R McKay, including the following topics:
- Prostate Cancer Working Group (PCWG4) revised terminology (0:00)
- Cardiovascular effects associated with GnRH agonists versus antagonists; mechanism of action (2:17)
- Combination therapy using relugolix; factors affecting persistence and adherence to GnRH agents (12:06)
- Takeaways from the Phase III EMBARK study (19:36)
- Use of CAR (chimeric antigen receptor) T-cell therapy and T-cell engagers (27:20)
- Potential role of circulating tumor DNA minimal residual disease testing; use of olaparib/radium-223 (29:24)
CME information and select publications
adbl_web_anon_alc_button_suppression_t1
No reviews yet